Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Zyneyro ApS
APS
Active
Advertising protection
CVR 42057428
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2021 · 5 years old
10 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Zyneyro ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
0M
2021
0M
2022
1M
2023
4M
2024
-5M
2025
EBITDA
DKK millions
1M
-2M
-5M
-8M
-11M
0M
2021
0M
0%
2022
0M
0%
2023
1M
+100%
2024
-9M
-1000%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-27
-27
1.030
4.169
-4.551
Staff expenses
-0
-0
-972
-3.458
-4.676
EBITDA
-27
-27
58
711
-9.227
Depreciation & amort.
-0
-0
-0
-0
-28
EBIT
-27
-27
58
711
-9.255
Net financials
-2
-1
-92
-2
-18
Profit before tax
-29
-28
-35
709
-9.273
Tax
-0
-0
-0
43
-1.806
Net profit
-29
-28
-35
666
-7.466
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
464
857
540
1.417
5.269
Equity
11
-18
-52
614
4.147
Long-term debt
0
0
0
0
0
Short-term debt
453
875
592
803
1.122
Total debt
453
875
592
803
1.122
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-922700800.0%
This company
2021
2025
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
2021
2025
Return on equity
-180.0%
This company
18.4%
Market median
-1078% vs market
2021
2025
Net profit margin (of gross profit)
-746644600.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.86×
This company
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-26 – 2021-12-31
View
PDF
More on Zyneyro ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
